Profile
Andrew Obenshain currently works at Inventiva SA, as Chief Executive Officer & Director from 2025, bluebird bio (UK) Ltd., as Director from 2017, and Biotechnology Innovation Organization, as Director.
Mr. Obenshain also formerly worked at bluebird bio, Inc., as President, Chief Executive Officer & Director from 2021 to 2025 and Shire Pharmaceuticals, Inc., as General Manager-France & Benelux from 2015 to 2016.
Mr. Obenshain received his undergraduate degree from Dartmouth College and Masters Business Admin degree from Kellogg School of Management.
Andrew Obenshain active positions
| Companies | Position | Start |
|---|---|---|
| INVENTIVA | Chief Executive Officer | 2025-09-30 |
bluebird bio (UK) Ltd.
bluebird bio (UK) Ltd. BiotechnologyHealth Technology Engages in research and development on biotechnology | Director/Board Member | 2017-03-29 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Director/Board Member | - |
Former positions of Andrew Obenshain
| Companies | Position | End |
|---|---|---|
| GENETIX BIOTHERAPEUTICS, INC. | Chief Executive Officer | 2025-06-01 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 2016-08-31 |
Training of Andrew Obenshain
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Dartmouth College
Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
bluebird bio, Inc.
bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inventiva SA
Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases | Health Technology |
bluebird bio (UK) Ltd.
bluebird bio (UK) Ltd. BiotechnologyHealth Technology Engages in research and development on biotechnology | Health Technology |
- Stock Market
- Insiders
- Andrew Obenshain
















